Enterprise value of top companies in non-oncology rare disease therapeutics 2017

Enterprise value of leading pure players in non-oncology rare disease therapeutics worldwide as of 2017 (in million U.S. dollars)*

Enterprise value of top companies in non-oncology rare disease therapeutics 2017 This statistic shows the enterprise value of leading pure players in non-oncology rare disease therapeutics worldwide as of 2017. In 2017, the value of Biogen which manufactures especially multiple sclerosis therapeutics stood at nearly 70 billion U.S. dollars.
Show more

Enterprise value of leading pure players in non-oncology rare disease therapeutics worldwide as of 2017 (in million U.S. dollars)*

Loading statistic...
Expand statistic
Value in million U.S. dollars
Biogen69,812
Shire (+predecessors)67,777
Vertex Pharma37,428
Genzyme36,070
Alexion33,114
BioMarin16,261
Jazz Pharma10,141
Bioverativ6,086
Ionis Pharma6,053
bluebird bio5,320
United Therapeutics4,225
Swedish Orphan Biovitrum4,073
Horizon Pharma3,409
Spark Therapeutics3,044
AveXis, Inc.2,671
Amicus Therapeutics2,416
Corcept Therapeutics2,127
Prothena Corporation2,060
Ultragenyx1,970
Intercept Pharma1,624
Value in million U.S. dollars
Biogen69,812
Shire (+predecessors)67,777
Vertex Pharma37,428
Genzyme36,070
Alexion33,114
BioMarin16,261
Jazz Pharma10,141
Bioverativ6,086
Ionis Pharma6,053
bluebird bio5,320
United Therapeutics4,225
Swedish Orphan Biovitrum4,073
Horizon Pharma3,409
Spark Therapeutics3,044
AveXis, Inc.2,671
Amicus Therapeutics2,416
Corcept Therapeutics2,127
Prothena Corporation2,060
Ultragenyx1,970
Intercept Pharma1,624
Download Settings Share
Download started
Please be patient - this may take a moment
This statistic shows the enterprise value of leading pure players in non-oncology rare disease therapeutics worldwide as of 2017. In 2017, the value of Biogen which manufactures especially multiple sclerosis therapeutics stood at nearly 70 billion U.S. dollars.
Show more
Statista Accounts: Access All Statistics. Starting from $588 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$49 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.
Leading companies trust Statista:
paypalgoogleadobepgsamsungtelekom
I think of Statista as Google for researchers. Statista provides you with the information you search for right away.
Dr. Horst Stipp

Dr. Horst Stipp
EVP, Research & Innovation, Advertising Research Foundation

Statistics on "Pharmaceutical trends in Europe"
  • Overview
The most important statistics
  • European Pharmaceutical companies
  • Self-medication market
  • Employment
  • Clinical Trials
Discover Statista
Need help with using Statista for your research? Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Learn more about how Statista can support your business.
Do you have any questions about our business solutions?

We provide you with detailed information about our Corporate Account.